Oluwadamilare, a 19-year-old pick-pocket, has just woken up to another Tuesday of highness in the notorious community of Akala, in the Mushin area of Lagos, Nigeria’s bustling commercial nerve-centre.
His tongue is dyed blue from licking five tablets of Rophypnol, a brand of Flunitrazepam. That
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
